MOLLY BERGLUND: Open Payments
NPI 1518390012 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 6 payments from 5 companies in 2025. Trend: 2023 $86 · 2024 $238 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $66 |
| Edwards Lifesciences Corporation | 1 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: Leqembi, SAPIEN 3 Ultra RESILIA, TZIELD, MOUNJARO, GEMTESA.
Industry payments across GA — which companies pay providers there.
